US7893101B2
(en)
*
|
2002-03-20 |
2011-02-22 |
Celgene Corporation |
Solid forms comprising (+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione, compositions thereof, and uses thereof
|
US7407955B2
(en)
|
2002-08-21 |
2008-08-05 |
Boehringer Ingelheim Pharma Gmbh & Co., Kg |
8-[3-amino-piperidin-1-yl]-xanthines, the preparation thereof and their use as pharmaceutical compositions
|
PL214032B1
(pl)
*
|
2003-03-03 |
2013-06-28 |
Array Biopharma |
Zwiazki bedace inhibitorami kinazy p38, kompozycja farmaceutyczna je zawierajaca oraz ich zastosowanie do wytwarzania leku do leczenia stanu, w którym posredniczy kinaza p38
|
US7135575B2
(en)
*
|
2003-03-03 |
2006-11-14 |
Array Biopharma, Inc. |
P38 inhibitors and methods of use thereof
|
US7344716B2
(en)
*
|
2003-05-13 |
2008-03-18 |
Depuy Spine, Inc. |
Transdiscal administration of specific inhibitors of pro-inflammatory cytokines
|
US7553827B2
(en)
*
|
2003-08-13 |
2009-06-30 |
Depuy Spine, Inc. |
Transdiscal administration of cycline compounds
|
US8273347B2
(en)
*
|
2003-05-13 |
2012-09-25 |
Depuy Spine, Inc. |
Autologous treatment of degenerated disc with cells
|
US7429378B2
(en)
*
|
2003-05-13 |
2008-09-30 |
Depuy Spine, Inc. |
Transdiscal administration of high affinity anti-MMP inhibitors
|
AU2004272104B2
(en)
*
|
2003-09-10 |
2011-09-08 |
Icagen, Inc |
Fused ring heterocycles as potassium channel modulators
|
JP4956191B2
(ja)
*
|
2003-10-17 |
2012-06-20 |
インサイト コーポレーション |
マトリックスメタロプロテイナーゼの阻害剤としての置換環状ヒドロキサメート
|
AU2006249350B2
(en)
|
2003-11-19 |
2012-02-16 |
Metabasis Therapeutics, Inc. |
Thyromimetics for the treatment of fatty liver diseases
|
US8895540B2
(en)
*
|
2003-11-26 |
2014-11-25 |
DePuy Synthes Products, LLC |
Local intraosseous administration of bone forming agents and anti-resorptive agents, and devices therefor
|
NZ547696A
(en)
|
2003-12-23 |
2009-12-24 |
Astex Therapeutics Ltd |
Pyrazole derivatives as protein kinase modulators
|
US7501426B2
(en)
|
2004-02-18 |
2009-03-10 |
Boehringer Ingelheim International Gmbh |
8-[3-amino-piperidin-1-yl]-xanthines, their preparation and their use as pharmaceutical compositions
|
RU2006134021A
(ru)
*
|
2004-02-27 |
2008-04-10 |
Ф.Хоффманн-Ля Рош Аг (Ch) |
Производные гетероарил-конденсированного пиразола
|
KR100843526B1
(ko)
*
|
2004-02-27 |
2008-07-03 |
에프. 호프만-라 로슈 아게 |
피라졸의 접합 유도체
|
BRPI0508107A
(pt)
*
|
2004-02-27 |
2007-07-17 |
Hoffmann La Roche |
derivados de indazol e composições farmacêuticas contendo os mesmos
|
ES2475207T3
(es)
|
2004-07-15 |
2014-07-10 |
Tetralogic Pharmaceuticals Corporation |
Compuestos de unión a IAP
|
WO2006018718A2
(en)
*
|
2004-08-12 |
2006-02-23 |
Pfizer Limited |
Triazolopyridinylsulfanyl derivatives as p38 map kinase inhibitors
|
EP1647549A1
(en)
*
|
2004-10-14 |
2006-04-19 |
Laboratoire Theramex |
Indazoles, benzisoxazoles and benzisothiazoles as estrogenic agents
|
DE102004054054A1
(de)
|
2004-11-05 |
2006-05-11 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Verfahren zur Herstellung chiraler 8-(3-Amino-piperidin-1-yl)-xanthine
|
KR101317661B1
(ko)
|
2005-02-25 |
2013-10-15 |
테트랄로직 파마슈티칼스 코포레이션 |
이량체성 iap 억제제
|
CN101146575A
(zh)
*
|
2005-03-22 |
2008-03-19 |
依奈特制药公司 |
新类型的γδT细胞活化剂及其应用
|
ES2382814T3
(es)
*
|
2005-05-17 |
2012-06-13 |
Merck Sharp & Dohme Ltd. |
Ácido cis-4-[(4-clorofenil)sulfonil]-4-(2,5-difluorofenil)ciclohexanopropanoico para el tratamiento del cáncer
|
US8343953B2
(en)
*
|
2005-06-22 |
2013-01-01 |
Astex Therapeutics Limited |
Pharmaceutical compounds
|
EP1933832A2
(en)
*
|
2005-06-23 |
2008-06-25 |
Astex Therapeutics Limited |
Pharmaceutical combinations comprising pyrazole derivatives as protein kinase modulators
|
ITRM20050344A1
(it)
*
|
2005-06-30 |
2007-01-01 |
Luca Maria De |
Sali o complessi di sostanze metil-donatrici con acido fitico o suoi derivati e relativo metodo di sintesi.
|
DE102005035891A1
(de)
|
2005-07-30 |
2007-02-08 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
8-(3-Amino-piperidin-1-yl)-xanthine, deren Herstellung und deren Verwendung als Arzneimittel
|
CA2618057A1
(en)
|
2005-08-11 |
2007-02-22 |
Vertex Pharmaceuticals Incorporated |
Modulators of cystic fibrosis transmembrane conductance regulator
|
EP1919914A2
(en)
*
|
2005-08-25 |
2008-05-14 |
F.Hoffmann-La Roche Ag |
P38 map kinase inhibitors and methods for using the same
|
BRPI0615442A2
(pt)
*
|
2005-08-25 |
2011-05-17 |
Hoffmann La Roche |
inibidores de p38 map cinase e métodos para uso dos mesmos
|
KR101390094B1
(ko)
*
|
2005-09-14 |
2014-04-28 |
산텐 세이야꾸 가부시키가이샤 |
글루코코르티코이드 수용체 결합 활성을 갖는 신규1,2-디히드로퀴놀린 유도체
|
EP1934219A1
(en)
|
2005-09-16 |
2008-06-25 |
Ranbaxy Laboratories Limited |
Substituted pyrazolo [3,4-b] pyridines as phosphodiesterase inhibitors
|
US20100022571A1
(en)
*
|
2005-09-16 |
2010-01-28 |
Palle Venkata P |
Substituted pyrazolo [3,4-b]pyridines as phosphodiesterase inhibitors
|
CN101365690A
(zh)
*
|
2005-10-12 |
2009-02-11 |
沃泰克斯药物股份有限公司 |
作为电压门控离子通道调控剂的联苯衍生物
|
WO2007047397A2
(en)
*
|
2005-10-13 |
2007-04-26 |
Smithkline Beecham Corporation |
Phenol ethers as modulators of the opioid receptors
|
CA2755268C
(en)
|
2005-11-15 |
2013-12-31 |
Array Biopharma, Inc. |
Erbb inhibitors
|
UA94921C2
(en)
*
|
2005-12-08 |
2011-06-25 |
Новартис Аг |
1-orthofluorophenyl substituted 1, 2, 5-thiazolidinedione derivatives as ptp-as inhibitors
|
WO2007087068A2
(en)
*
|
2006-01-13 |
2007-08-02 |
Pharmacyclics, Inc. |
Inhibitors of tyrosine kinases and uses thereof
|
PL1981851T3
(pl)
*
|
2006-01-31 |
2012-07-31 |
Array Biopharma Inc |
Inhibitory kinazy i sposoby ich stosowania
|
US8541406B2
(en)
*
|
2006-02-07 |
2013-09-24 |
Nv Remynd |
Thiadiazole derivatives for the treatment of neurodegenerative diseases
|
EP1852108A1
(en)
|
2006-05-04 |
2007-11-07 |
Boehringer Ingelheim Pharma GmbH & Co.KG |
DPP IV inhibitor formulations
|
PE20110235A1
(es)
|
2006-05-04 |
2011-04-14 |
Boehringer Ingelheim Int |
Combinaciones farmaceuticas que comprenden linagliptina y metmorfina
|
CN101437823B
(zh)
|
2006-05-04 |
2014-12-10 |
勃林格殷格翰国际有限公司 |
多晶型
|
WO2008005651A2
(en)
*
|
2006-06-08 |
2008-01-10 |
Decode Chemistry, Inc. |
Cyclic carboxylic acid rhodanine derivatives for the treatment and prevention of tuberculosis
|
US7727978B2
(en)
*
|
2006-08-24 |
2010-06-01 |
Bristol-Myers Squibb Company |
Cyclic 11-beta hydroxysteroid dehydrogenase type I inhibitors
|
JP2010503654A
(ja)
*
|
2006-09-12 |
2010-02-04 |
ファイザー・プロダクツ・インク |
ベンゾイミダゾロン誘導体
|
UA99600C2
(en)
|
2006-09-25 |
2012-09-10 |
ПиТиСи ТЕРАПЬЮТИКС, ИНК. |
Crystalline forms of 3-[5-(2-fhjorophenyl)-[1,2,4]oxadiazol-3-yl]-benzoic acid
|
US8008496B2
(en)
|
2006-11-14 |
2011-08-30 |
Santen Pharmaceutical Co., Ltd. |
1,2-dihydroquinoline derivative having substituted phenylchalcogeno lower alkyl group and ester-introduced phenyl group as substituents
|
TW200831085A
(en)
*
|
2006-12-13 |
2008-08-01 |
Merck & Co Inc |
Non-nucleoside reverse transcriptase inhibitors
|
DE102007009494A1
(de)
*
|
2007-02-27 |
2008-08-28 |
Bayer Healthcare Ag |
Substituierte 4-Aryl-1, 4-dihydro-1,6-naphthyridinamide und ihre Verwendung
|
AU2008226947B2
(en)
|
2007-03-08 |
2014-07-17 |
The Board Of Trustees Of The Leland Stanford Junior University |
Mitochondrial aldehyde dehydrogenase-2 modulators and methods of use thereof
|
US8030344B2
(en)
*
|
2007-03-13 |
2011-10-04 |
Methylgene Inc. |
Inhibitors of histone deacetylase
|
GB0704932D0
(en)
|
2007-03-14 |
2007-04-25 |
Astex Therapeutics Ltd |
Pharmaceutical compounds
|
WO2008116831A1
(en)
*
|
2007-03-23 |
2008-10-02 |
Abbott Gmbh & Co. Kg |
Quinoline compounds suitable for treating didorders that respond to modulation of the serotonin 5-ht6 receptor
|
WO2008118991A1
(en)
*
|
2007-03-26 |
2008-10-02 |
University Of Southern California Usc Stevens |
Methods and compositions for inducing apoptosis by stimulating er stress
|
MX2009011619A
(es)
*
|
2007-04-27 |
2010-01-18 |
Cydex Pharmaceuticals Inc |
Formulaciones que contienen clopidogrel y eter sulfoalquilico-ciclodextrina y metodos de uso.
|
EP2011786A1
(en)
*
|
2007-07-05 |
2009-01-07 |
Laboratorios del Dr. Esteve S.A. |
Indane-amine derivatives, their preparation and use as medicaments
|
DE102007032347A1
(de)
*
|
2007-07-11 |
2009-01-15 |
Bayer Healthcare Ag |
Aminoacyl-Prodrugs
|
US8202899B2
(en)
*
|
2007-07-25 |
2012-06-19 |
Array Biopharma Inc. |
Pyrazole urea derivatives used as kinase inhibitors
|
TW200908984A
(en)
*
|
2007-08-07 |
2009-03-01 |
Piramal Life Sciences Ltd |
Pyridyl derivatives, their preparation and use
|
EP2188257A2
(en)
*
|
2007-08-07 |
2010-05-26 |
Cadila Healthcare Limited |
Sulfoximine derivatives as factor xa inhibitors
|
WO2009026579A1
(en)
*
|
2007-08-23 |
2009-02-26 |
Cornell Research Foundation, Inc. |
Proteasome inhibitors and their use in treating pathogen infection and cancer
|
US20100292292A1
(en)
*
|
2007-09-13 |
2010-11-18 |
Link Medicine Corporation |
Treatment of Neurodegenerative Diseases Using Indatraline Analogs
|
US10435356B1
(en)
|
2007-09-18 |
2019-10-08 |
Thermolife International, Llc |
Amino acid compositions
|
US10646508B1
(en)
*
|
2007-09-18 |
2020-05-12 |
Thermolife International, Llc |
Method of safely administering nitrate dietary supplements and compositions
|
US10426750B1
(en)
|
2007-09-18 |
2019-10-01 |
Thermolife International, Llc |
Amino acid supplement formulations
|
US8466187B2
(en)
|
2007-09-18 |
2013-06-18 |
Thermolife International, Llc |
Amino acid compositions
|
JP2011503232A
(ja)
|
2007-11-20 |
2011-01-27 |
ザ ブリガム アンド ウィメンズ ホスピタル インコーポレイテッド |
免疫応答の調節
|
US20120142766A1
(en)
*
|
2007-11-21 |
2012-06-07 |
Evolva Sa |
Substituted 1,3-dioxanes and their uses
|
FR2924712B1
(fr)
*
|
2007-12-06 |
2012-12-21 |
Univ Maine |
Derives du gossypol et de l'apogossypol, leurs preparations et leurs applications
|
EP2070929A1
(en)
|
2007-12-11 |
2009-06-17 |
Bayer Schering Pharma Aktiengesellschaft |
Alkynylaryl compounds and salts thereof, pharmaceutical compositions comprising same, methods of preparing same and uses of same
|
AR069650A1
(es)
*
|
2007-12-14 |
2010-02-10 |
Actelion Pharmaceuticals Ltd |
Derivados de aminopirazol como agonistas no peptidicos del receptor alx humano
|
US20090162351A1
(en)
*
|
2007-12-21 |
2009-06-25 |
Depuy Spine, Inc. |
Transdiscal administration of inhibitors of p38 MAP kinase
|
US8986696B2
(en)
*
|
2007-12-21 |
2015-03-24 |
Depuy Mitek, Inc. |
Trans-capsular administration of p38 map kinase inhibitors into orthopedic joints
|
WO2009108499A1
(en)
*
|
2008-02-25 |
2009-09-03 |
Merck & Co., Inc. |
Tetrahydro-1h-pyrrolo fused pyridones
|
JP2011513329A
(ja)
*
|
2008-02-29 |
2011-04-28 |
アレイ バイオファーマ、インコーポレイテッド |
RAF阻害化合物として使用されるイミダゾ[4,5−b]ピリジン誘導体
|
NZ587799A
(en)
*
|
2008-03-25 |
2012-06-29 |
Affectis Pharmaceuticals Ag |
Novel p2x7r antagonists and their use
|
US20090246234A1
(en)
*
|
2008-04-01 |
2009-10-01 |
Benjamin Johnson |
Therapeutic Treatment Using Niacin for Skin Disorders
|
PE20091730A1
(es)
|
2008-04-03 |
2009-12-10 |
Boehringer Ingelheim Int |
Formulaciones que comprenden un inhibidor de dpp4
|
EP2116539A1
(en)
|
2008-04-25 |
2009-11-11 |
Laboratorios Del. Dr. Esteve, S.A. |
1-aryl-3-aminoalkoxy-pyrazoles as sigma ligands enhancing analgesic effects of opioids and attenuating the dependency thereof
|
WO2009144009A1
(en)
*
|
2008-05-26 |
2009-12-03 |
Medizinische Universität Innsbruck |
Medical intervention in haematological cancers
|
EP2733147A1
(en)
*
|
2008-06-17 |
2014-05-21 |
Millennium Pharmaceuticals, Inc. |
Boronate ester compounds and pharmaceutical compositions thereof
|
CN102123986B
(zh)
*
|
2008-06-25 |
2013-08-28 |
学校法人庆应义塾 |
药物组合物
|
WO2010017350A1
(en)
*
|
2008-08-06 |
2010-02-11 |
Vertex Pharmaceuticals Incorporated |
Aminopyridine kinase inhibitors
|
BRPI0916997A2
(pt)
|
2008-08-06 |
2020-12-15 |
Boehringer Ingelheim International Gmbh |
Inibidor de dpp-4 e seu uso
|
UY32030A
(es)
|
2008-08-06 |
2010-03-26 |
Boehringer Ingelheim Int |
"tratamiento para diabetes en pacientes inapropiados para terapia con metformina"
|
ES2477552T3
(es)
|
2008-09-08 |
2014-07-17 |
The Board Of Trustees Of The Leland Stanford Junior University |
Moduladores de la actividad de la aldehidodeshidrogenasa y métodos de uso de los mismos
|
KR20110067096A
(ko)
*
|
2008-09-10 |
2011-06-21 |
베링거 인겔하임 인터내셔날 게엠베하 |
당뇨병 및 관련 상태를 치료하기 위한 병용 요법
|
KR100905419B1
(ko)
*
|
2008-09-11 |
2009-07-02 |
연세대학교 산학협력단 |
세스퀴테르펜 유도체의 용도
|
EP2617414A3
(en)
*
|
2008-10-01 |
2013-11-06 |
Novartis AG |
Smoothened antagonism for the treatment of hedgehog pathway-related disorders
|
WO2010041908A2
(ko)
*
|
2008-10-09 |
2010-04-15 |
(주)뉴트리 |
판두라틴 유도체 또는 보에센베르기아 판두라타 추출물의 신규한 용도
|
AR074797A1
(es)
*
|
2008-10-10 |
2011-02-16 |
Japan Tobacco Inc |
Compuesto de fluoreno , composiciones farmaceuticas , inhibidores de pdhk y pdhk2 , metodos de tratamiento , usos de los mismos y kit comercial
|
US20200155558A1
(en)
|
2018-11-20 |
2020-05-21 |
Boehringer Ingelheim International Gmbh |
Treatment for diabetes in patients with insufficient glycemic control despite therapy with an oral antidiabetic drug
|
WO2010062308A1
(en)
*
|
2008-10-28 |
2010-06-03 |
The Board Of Trustees Of The Leland Stanford Junior University |
Modulators of aldehyde dehydrogenase and methods of use thereof
|
DE102008059133A1
(de)
*
|
2008-11-26 |
2010-05-27 |
Merck Patent Gmbh |
Difluorphenyl-diacylhydrazid-derivate
|
KR20100060189A
(ko)
*
|
2008-11-27 |
2010-06-07 |
국립암센터 |
에타크리닉 산을 포함하는 트란스글루타미나제 관련 질환 예방 또는 치료용 조성물 및 그를 이용하는 트란스글루타미나제 관련 질환 예방 또는 치료 방법
|
US8362080B2
(en)
*
|
2008-12-18 |
2013-01-29 |
Baylor College Of Medicine |
Increasing glutathione levels for therapy
|
TWI432188B
(zh)
*
|
2008-12-19 |
2014-04-01 |
Merz Pharma Gmbh & Co Kgaa |
供治療發炎性皮膚疾病之1-胺基-烷基環己烷衍生物類
|
KR20110103968A
(ko)
|
2008-12-23 |
2011-09-21 |
베링거 인겔하임 인터내셔날 게엠베하 |
유기 화합물의 염 형태
|
AR074990A1
(es)
|
2009-01-07 |
2011-03-02 |
Boehringer Ingelheim Int |
Tratamiento de diabetes en pacientes con un control glucemico inadecuado a pesar de la terapia con metformina
|
US9314444B2
(en)
*
|
2009-01-12 |
2016-04-19 |
Biokier, Inc. |
Composition and method for treatment of NASH
|
US9006288B2
(en)
|
2009-01-12 |
2015-04-14 |
Biokier, Inc. |
Composition and method for treatment of diabetes
|
AU2010203413B2
(en)
*
|
2009-01-12 |
2015-05-14 |
Biokier Inc. |
Composition and method for treatment of diabetes
|
WO2010081488A1
(en)
*
|
2009-01-15 |
2010-07-22 |
Humanitas Mirasole S.P.A. |
Nitric oxide furoxan derivative compounds endowed with antitumoral activity
|
WO2010084160A1
(en)
|
2009-01-21 |
2010-07-29 |
Oryzon Genomics S.A. |
Phenylcyclopropylamine derivatives and their medical use
|
US20100204329A1
(en)
*
|
2009-02-06 |
2010-08-12 |
Mcfaul William J |
Method of using and establishing an absorption rate level and a neuron firing level
|
WO2010093601A1
(en)
*
|
2009-02-10 |
2010-08-19 |
Metabasis Therapeutics, Inc. |
Novel sulfonic acid-containing thyromimetics, and methods for their use
|
ES2345241B1
(es)
|
2009-03-16 |
2011-09-08 |
Lipopharma Therapeutics |
Uso de 2-hidroxiderivados de acidos grasos poliinsaturados como medicamentos.
|
EP2411001B1
(en)
*
|
2009-03-23 |
2018-01-17 |
Merck Sharp & Dohme Corp. |
P2x3, receptor antagonists for treatment of pain
|
US8946204B2
(en)
|
2009-05-07 |
2015-02-03 |
Gruenenthal Gmbh |
Substituted phenylureas and phenylamides as vanilloid receptor ligands
|
WO2010127856A1
(en)
*
|
2009-05-07 |
2010-11-11 |
Grünenthal GmbH |
Substituted phenyllureas and phenylamides as vanilloid receptor ligands
|
WO2010132711A1
(en)
|
2009-05-13 |
2010-11-18 |
Cydex Pharmaceuticals, Inc. |
Pharmaceutical compositions comprising prasugrel and cyclodextrin derivatives and methods of making and using the same
|
CN102639133B
(zh)
*
|
2009-06-12 |
2015-03-11 |
联合治疗公司 |
亚氨基糖和治疗布尼亚病毒性疾病以及披膜病毒性疾病的方法
|
US8283372B2
(en)
|
2009-07-02 |
2012-10-09 |
Tetralogic Pharmaceuticals Corp. |
2-(1H-indol-3-ylmethyl)-pyrrolidine dimer as a SMAC mimetic
|
EA201290073A1
(ru)
*
|
2009-08-24 |
2013-01-30 |
Эсэпиен Фармасьютикалз, Инк. |
Соединения мочевины, содержащие 5,6-бициклический гетероарил, как ингибиторы киназ
|
WO2011032320A1
(en)
*
|
2009-09-21 |
2011-03-24 |
F. Hoffmann-La Roche Ag |
Novel alkene oxindole derivatives
|
WO2011036576A1
(en)
*
|
2009-09-23 |
2011-03-31 |
Pfizer Inc. |
Gpr 119 modulators
|
RU2602814C2
(ru)
|
2009-09-25 |
2016-11-20 |
Оризон Дженомикс С.А. |
Лизинспецифические ингибиторы деметилазы-1 и их применение
|
WO2011042217A1
(en)
|
2009-10-09 |
2011-04-14 |
Oryzon Genomics S.A. |
Substituted heteroaryl- and aryl- cyclopropylamine acetamides and their use
|
EA034869B1
(ru)
|
2009-11-27 |
2020-03-31 |
Бёрингер Ингельхайм Интернациональ Гмбх |
Лечение генотипированных пациентов с диабетом ингибиторами дпп-4, такими как линаглиптин
|
AU2011210352A1
(en)
*
|
2010-01-26 |
2012-08-09 |
Radikal Therapeutics Inc. |
Compositions and methods for prevention and treatment of pulmonary hypertension
|
US8563610B2
(en)
*
|
2010-02-04 |
2013-10-22 |
Rutgers, The State of New Jersey |
Polyunsaturated fatty acids interactions and oxidative stress disorders
|
EP2353591A1
(en)
|
2010-02-04 |
2011-08-10 |
Laboratorios Del. Dr. Esteve, S.A. |
Sigma ligands for potentiating the analgesic effect of opioids and opiates in post-operative pain and attenuating the dependency thereof
|
RU2012139491A
(ru)
*
|
2010-02-11 |
2014-03-20 |
Вандербилт Юниверсити |
Бензизоксазолы и азабензизоксазолы как аллостерические потенциаторы mglur4, композиции и способы лечения неврологических дисфункций
|
HUE032860T2
(en)
|
2010-02-12 |
2017-11-28 |
Chimerix Inc |
A method for treating a virus infection
|
US9616058B2
(en)
|
2010-02-24 |
2017-04-11 |
Oryzon Genomics, S.A. |
Potent selective LSD1 inhibitors and dual LSD1/MAO-B inhibitors for antiviral use
|
WO2011106573A2
(en)
|
2010-02-24 |
2011-09-01 |
Oryzon Genomics, S.A. |
Lysine demethylase inhibitors for diseases and disorders associated with hepadnaviridae
|
CN105616402A
(zh)
*
|
2010-03-08 |
2016-06-01 |
光谱医药公司 |
治疗癌症的基于噻吨酮的自噬抑制剂疗法
|
ES2607081T3
(es)
*
|
2010-04-19 |
2017-03-29 |
Oryzon Genomics, S.A. |
Inhibidores de desmetilasa específica de lisina-1 y su uso
|
US20130231360A1
(en)
*
|
2010-04-22 |
2013-09-05 |
The Brigham And Women S Hospital, Inc. |
Beta-Carbolines as Inhibitors of Haspin and DYRK Kinases
|
WO2011139709A2
(en)
|
2010-04-26 |
2011-11-10 |
Chimerix, Inc. |
Methods of treating retroviral infections and related dosage regimes
|
WO2011137046A1
(en)
*
|
2010-04-29 |
2011-11-03 |
Merck Sharp & Dohme Corp. |
Substituted 1,3-benzothiazol-2(3h)-ones and [1,3]thiazolo[5,4-b]pyridin-2(1h)-ones as positive allosteric modulators of mglur2
|
BR112012028136A2
(pt)
|
2010-05-05 |
2016-08-09 |
Boehringer Ingelheim Int |
terapia de combinaçao
|
GB201008005D0
(en)
*
|
2010-05-13 |
2010-06-30 |
Sentinel Oncology Ltd |
Pharmaceutical compounds
|
EP3354635A1
(en)
*
|
2010-05-14 |
2018-08-01 |
Agency For Science, Technology And Research |
Novel antimicrobial compounds and uses thereof
|
EP2388005A1
(en)
|
2010-05-21 |
2011-11-23 |
Laboratorios Del. Dr. Esteve, S.A. |
Sigma ligands for the prevention and/or treatment of emesis induced by chemotherapy or radiotherapy
|
AU2011258553B2
(en)
*
|
2010-05-27 |
2014-08-14 |
Targacept, Inc. |
Nicotinic receptor non-competitive antagonists
|
GB201010359D0
(en)
*
|
2010-06-21 |
2010-08-04 |
Univ Nottingham |
Compounds for treating proliferative disorders
|
KR20130093012A
(ko)
|
2010-06-24 |
2013-08-21 |
베링거 인겔하임 인터내셔날 게엠베하 |
당뇨병 요법
|
EP2585066B1
(en)
*
|
2010-06-24 |
2018-09-26 |
Alkermes Pharma Ireland Limited |
Prodrugs of nh-acidic compounds: ester, carbonate, carbamate and phosphonate derivatives
|
TW201204733A
(en)
*
|
2010-06-25 |
2012-02-01 |
Kowa Co |
Novel condensed pyridine or condensed pyrimidine derivative, and medicinal agent comprising same
|
US8846671B2
(en)
*
|
2010-07-01 |
2014-09-30 |
Guangzhou Institute Of Biomedicine And Health, Chinese Academy Of Sciences |
Heterocyclic alkynyl benzene compounds and medical compositions and uses thereof
|
US20130184273A1
(en)
*
|
2010-07-13 |
2013-07-18 |
Bayer Intellectual Property Gmbh |
Bicyclic pyrimidines
|
CA2806655A1
(en)
|
2010-07-28 |
2012-02-02 |
Bayer Intellectual Property Gmbh |
Substituted imidazo[1,2-b]pyridazines
|
RU2611437C2
(ru)
|
2010-07-29 |
2017-02-22 |
Оризон Дженомикс С.А. |
Ингибиторы деметилазы lsd1 на основе арилциклопропиламина и их применение в медицине
|
WO2012013727A1
(en)
|
2010-07-29 |
2012-02-02 |
Oryzon Genomics S.A. |
Cyclopropylamine derivatives useful as lsd1 inhibitors
|
EP2599774B1
(en)
*
|
2010-07-29 |
2016-07-06 |
Astellas Pharma Inc. |
Condensed pyridine compounds as cb2 cannabinoid receptor ligands
|
EP2415471A1
(en)
|
2010-08-03 |
2012-02-08 |
Laboratorios Del. Dr. Esteve, S.A. |
Use of sigma ligands in opioid-induced hyperalgesia
|
PL392436A1
(pl)
*
|
2010-09-17 |
2012-03-26 |
Adamed Spółka Z Ograniczoną Odpowiedzialnością |
Pochodne arylosulfonamidów do leczenia chorób odśrodkowego układu nerwowego
|
JP2013538784A
(ja)
*
|
2010-10-01 |
2013-10-17 |
ラクオリア創薬株式会社 |
Trpm8拮抗剤としてのスルファモイル安息香酸ヘテロ二環性誘導体
|
WO2012045883A1
(en)
|
2010-10-08 |
2012-04-12 |
Oryzon Genomics S.A. |
Cyclopropylamine inhibitors of oxidases
|
WO2012051659A1
(en)
*
|
2010-10-20 |
2012-04-26 |
Biota Scientific Management Pty Ltd |
Viral polymerase inhibitors
|
TWI537258B
(zh)
|
2010-11-05 |
2016-06-11 |
百靈佳殷格翰國際股份有限公司 |
六氫茚并吡啶及八氫苯并喹啉之芳基-及雜環芳基羰基衍生物
|
US9034883B2
(en)
|
2010-11-15 |
2015-05-19 |
Boehringer Ingelheim International Gmbh |
Vasoprotective and cardioprotective antidiabetic therapy
|
JP5897590B2
(ja)
*
|
2010-11-24 |
2016-03-30 |
メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツングMerck Patent Gesellschaft mit beschraenkter Haftung |
キナゾリンカルボキサミドアゼチジン
|
WO2012072713A2
(en)
|
2010-11-30 |
2012-06-07 |
Oryzon Genomics, S.A. |
Lysine demethylase inhibitors for diseases and disorders associated with flaviviridae
|
US9096504B2
(en)
*
|
2010-12-01 |
2015-08-04 |
Washington State University |
Controlled chemical release of hydrogen sulfide
|
US8796338B2
(en)
|
2011-01-07 |
2014-08-05 |
Elcelyx Therapeutics, Inc |
Biguanide compositions and methods of treating metabolic disorders
|
US9480663B2
(en)
|
2011-01-07 |
2016-11-01 |
Elcelyx Therapeutics, Inc. |
Biguanide compositions and methods of treating metabolic disorders
|
US11759441B2
(en)
|
2011-01-07 |
2023-09-19 |
Anji Pharmaceuticals Inc. |
Biguanide compositions and methods of treating metabolic disorders
|
US9211263B2
(en)
|
2012-01-06 |
2015-12-15 |
Elcelyx Therapeutics, Inc. |
Compositions and methods of treating metabolic disorders
|
US9572784B2
(en)
|
2011-01-07 |
2017-02-21 |
Elcelyx Therapeutics, Inc. |
Compositions comprising statins, biguanides and further agents for reducing cardiometabolic risk
|
DK2661266T3
(da)
|
2011-01-07 |
2020-11-16 |
Anji Pharma Us Llc |
Kemosensoriske receptorligandbaserede terapier
|
US9050347B2
(en)
*
|
2011-01-25 |
2015-06-09 |
Viviabiotech, S.L. |
1,2,4-oxadiazole derivatives as drugs modulating the GLP-1 peptide receptor
|
EP2712315B1
(en)
|
2011-02-08 |
2021-11-24 |
Oryzon Genomics, S.A. |
Lysine demethylase inhibitors for myeloproliferative disorders
|
US20120208872A1
(en)
*
|
2011-02-11 |
2012-08-16 |
Taipei Medical University |
Use of tea polyphenols for treating and/or preventing nicotine or nicotine-derived compounds or estrogen induced breast cancer
|
EP2677869B1
(en)
*
|
2011-02-25 |
2017-11-08 |
Merck Sharp & Dohme Corp. |
Novel cyclic azabenzimidazole derivatives useful as anti-diabetic agents
|
US8642655B2
(en)
*
|
2011-03-09 |
2014-02-04 |
Benjamin Johnson |
Systems and methods for preventing cancer and treating skin lesions
|
PL2685827T3
(pl)
*
|
2011-03-18 |
2016-07-29 |
Corcept Therapeutics Inc |
Pirymidyno-cykloheksylowe modulatory receptora glikokortykoidowego
|
US9018257B2
(en)
*
|
2011-03-24 |
2015-04-28 |
Bar Ilan University |
5-aminolevulinic acid derivatives, methods for their preparation and uses thereof
|
WO2012135631A1
(en)
*
|
2011-03-30 |
2012-10-04 |
Arrien Pharmaeuticals Llc |
Substituted 5-(pyrazin-2-yl)-1h-pyrazolo [3, 4-b] pyridine and pyrazolo [3, 4-b] pyridine derivatives as protein kinase inhibitors
|
AU2012242565B2
(en)
|
2011-04-13 |
2017-05-11 |
Thermolife International, Llc |
N-Acetyl Beta Alanine methods of use
|
ES2617215T3
(es)
*
|
2011-04-19 |
2017-06-15 |
Daiichi Sankyo Company, Limited |
Derivado de tetrahirotiazepina
|
WO2012149106A1
(en)
|
2011-04-29 |
2012-11-01 |
The Board Of Trustees Of The Leland Stanford Junior University |
Compositions and methods for increasing proliferation of adult salivary stem cells
|
EP2524694A1
(en)
*
|
2011-05-19 |
2012-11-21 |
Laboratorios Del. Dr. Esteve, S.A. |
Use of sigma ligands in diabetes type-2 associated pain
|
US8487008B2
(en)
*
|
2011-06-22 |
2013-07-16 |
Universita Degli Studi Di Padova |
Treatment of muscular dystrophies and associated conditions by administration of monoamine oxidase inhibitors
|
WO2012177263A1
(en)
|
2011-06-24 |
2012-12-27 |
Intra-Cellular Therapies, Inc. |
Compounds and methods of prophylaxis and treatment regarding nictonic receptor antagonists
|
US8658677B2
(en)
*
|
2011-07-07 |
2014-02-25 |
Aria Neurosciences Inc. |
Pyridyl-2-methylamino compounds, compositions and uses thereof
|
EP2731947B1
(en)
|
2011-07-15 |
2019-01-16 |
Boehringer Ingelheim International GmbH |
Substituted dimeric quinazoline derivative, its preparation and its use in pharmaceutical compositions for the treatment of type i and ii diabetes
|
UA113291C2
(xx)
|
2011-08-04 |
2017-01-10 |
|
Метаболіти транскломіфену і їх застосування
|
TW201311679A
(zh)
*
|
2011-08-04 |
2013-03-16 |
Takeda Pharmaceutical |
含氮雜環化合物
|
US9040567B2
(en)
*
|
2011-08-19 |
2015-05-26 |
Emory University |
BAX agonist, compositions, and methods related thereto
|
DK2755483T3
(da)
|
2011-09-14 |
2019-03-11 |
Samumed Llc |
Indazol-3-carboxamider og anvendelse deraf som wnt/b-cateninsignalvejshæmmere
|
TWI568735B
(zh)
*
|
2011-09-14 |
2017-02-01 |
吉斯藥品公司 |
新穎化合物
|
AU2012314587A1
(en)
|
2011-09-26 |
2014-03-06 |
Grünenthal GmbH |
Aryl or N-heteroaryl substituted methanesulfonamide derivatives as vanilloid receptor ligands
|
AR088003A1
(es)
*
|
2011-09-26 |
2014-04-30 |
Gruenenthal Gmbh |
Derivados de metansulfonamida sustituidos con amina como ligandos del receptor de vanilloide
|
JP6046154B2
(ja)
|
2011-10-20 |
2016-12-14 |
オリソン ヘノミクス エセ. アー. |
Lsd1阻害剤としての(ヘテロ)アリールシクロプロピルアミン化合物
|
US9487512B2
(en)
|
2011-10-20 |
2016-11-08 |
Oryzon Genomics S.A. |
(Hetero)aryl cyclopropylamine compounds as LSD1 inhibitors
|
CN104136031B
(zh)
|
2011-10-26 |
2016-05-04 |
凯姆制药公司 |
氢***酮的苯甲酸缀合物、苯甲酸衍生物缀合物和杂芳基羧酸缀合物、其前药、制备和使用方法
|
CA2856235A1
(en)
*
|
2011-11-13 |
2013-05-16 |
Blanchette Rockefeller Neurosciences Institute |
Esters of dcpla for the treatment of neurodegenerative disorders
|
WO2013078059A1
(en)
|
2011-11-22 |
2013-05-30 |
Trustees Of Tufts College |
Small molecule enhancer for dendritic cell cancer vaccines
|
CA2857109A1
(en)
*
|
2011-12-05 |
2013-06-13 |
Glenmark Pharmaceuticals S.A. |
Pharmaceutical composition comprising a trpa1 antagonist and an anticholinergic agent
|
EA033067B1
(ru)
|
2012-01-06 |
2019-08-30 |
Элселикс Терапьютикс, Инк. |
Способ лечения метаболических расстройств у пациента, имеющего противопоказание к назначению бигуанидного соединения
|
CN110693868A
(zh)
|
2012-01-06 |
2020-01-17 |
埃尔舍利克斯治疗公司 |
双胍组合物和治疗代谢性病症的方法
|
CN102603493B
(zh)
*
|
2012-01-17 |
2014-03-12 |
青岛农业大学 |
含氟邻烯丙基苯酚类化合物的制备方法及农用生物活性
|
MX2014009154A
(es)
*
|
2012-02-14 |
2014-08-27 |
Repros Therapeutics Inc |
Moduladores selectivos del receptor estrogenico con vidas medias cortas y usos de los mismos.
|
CN102614177B
(zh)
*
|
2012-03-06 |
2014-08-06 |
北京伟峰益民科技有限公司 |
卢帕他定在制备治疗慢性阻塞性肺病药物组合物中的应用
|
US9555001B2
(en)
|
2012-03-07 |
2017-01-31 |
Boehringer Ingelheim International Gmbh |
Pharmaceutical composition and uses thereof
|
EP2830613B1
(en)
*
|
2012-03-30 |
2016-04-27 |
Nestec S.A. |
4-oxo-2-pentenoic acid and cardiovascular health
|
US9499484B2
(en)
*
|
2012-04-02 |
2016-11-22 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd |
Indole, indoline derivatives, compositions comprising them and uses thereof
|
PH12017500997A1
(en)
|
2012-04-04 |
2018-02-19 |
Samumed Llc |
Indazole inhibitors of the wnt signal pathway and therapeutic uses thereof
|
RU2014139971A
(ru)
*
|
2012-04-04 |
2016-04-20 |
КЬЕЗИ ФАРМАЧЕУТИЧИ С.п.А. |
Производные 1-(2-галогенобифенил-4-ил) алканкарбоновых кислот для лечения нейродегенеративных заболеваний
|
US8809376B2
(en)
*
|
2012-04-30 |
2014-08-19 |
Boehringer Ingelheim International Gmbh |
Indanyloxydihydrobenzofuranylacetic acids
|
JP6224084B2
(ja)
|
2012-05-14 |
2017-11-01 |
ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング |
糸球体上皮細胞関連障害及び/又はネフローゼ症候群の治療に用いるdpp−4阻害薬としてのキサンチン誘導体
|
WO2013174767A1
(en)
|
2012-05-24 |
2013-11-28 |
Boehringer Ingelheim International Gmbh |
A xanthine derivative as dpp -4 inhibitor for use in modifying food intake and regulating food preference
|
US8859774B2
(en)
|
2012-05-25 |
2014-10-14 |
Corcept Therapeutics, Inc. |
Heteroaryl-ketone fused azadecalin glucocorticoid receptor modulators
|
WO2013192350A1
(en)
*
|
2012-06-20 |
2013-12-27 |
Vanderbilt University |
Substituted bicyclic aralkyl pyrazole lactam analogs as allosteric modulators of mglur5 receptors
|
EP2863922A4
(en)
*
|
2012-06-20 |
2015-11-04 |
Univ Vanderbilt |
SUBSTITUTED BICYCLIC ALKOXYPYRAZOL ANALOGUES AS ALLOSTERIC MODULATORS OF MGLUR5 RECEPTORS
|
CA2879431A1
(en)
|
2012-07-17 |
2014-01-23 |
Washington University |
Anti-mucus drugs and uses therefor
|
JP6320382B2
(ja)
|
2012-08-13 |
2018-05-09 |
ザ ロックフェラー ユニヴァーシティ |
メラノーマの処置および診断
|
US10208043B2
(en)
|
2012-08-22 |
2019-02-19 |
Cornell University |
Methods for inhibiting fascin
|
CN104602690A
(zh)
*
|
2012-08-29 |
2015-05-06 |
默克专利股份有限公司 |
用于治疗骨关节炎的ddr2抑制剂
|
US8859598B2
(en)
*
|
2012-10-04 |
2014-10-14 |
Allergan, Inc. |
1, 2, 4-oxadiazoles azetidine derivatives as sphingosine-1 phosphate receptors modulators
|
US9278081B2
(en)
*
|
2012-10-04 |
2016-03-08 |
University Of The West Indies |
Extracts from Eucalyptus camaldulensis for the treatment of hyperglycemia and hypertension
|
EP2914294A1
(en)
|
2012-11-02 |
2015-09-09 |
Repros Therapeutics Inc. |
Trans-clomiphene for use in cancer therapy
|
US9624214B2
(en)
|
2012-11-05 |
2017-04-18 |
Bayer Pharma Aktiengesellschaft |
Amino-substituted imidazo[1,2-a]pyridinecarboxamides and their use
|
US9163027B2
(en)
*
|
2012-11-21 |
2015-10-20 |
Stategics, Inc. |
Substituted triazolo-pyrimidine compounds for modulating cell proliferation differentiation and survival
|
CN104822669A
(zh)
*
|
2012-12-05 |
2015-08-05 |
奇斯药制品公司 |
作为pde-4抑制剂的苯基乙基吡啶衍生物
|
US20140163025A1
(en)
|
2012-12-07 |
2014-06-12 |
Boehringer Ingelheim International Gmbh |
Indanyloxydihydrobenzofuranylacetic acids
|
UY35212A
(es)
|
2012-12-21 |
2014-06-30 |
Gilead Sciences Inc |
Inhibidores de la quinasa que regula la señal de la apoptosis
|
MX370487B
(es)
|
2013-01-08 |
2019-12-16 |
Samumed Llc |
Inhibidores de 3-(benzo-imidazol-2-il)-indazol de la senda de señalización de wnt y usos terapéuticos de los mismos.
|
CU20130027A7
(es)
*
|
2013-02-28 |
2014-10-30 |
Ct De Neurociencias De Cuba |
Chaperoninas químicas como nuevos moduladores moleculares de la beta agregación proteica presente en las enfermedades conformacionales
|
WO2014153214A1
(en)
|
2013-03-14 |
2014-09-25 |
Epizyme, Inc. |
Arginine methyl transferase inhibtors and uses thereof
|
US9447079B2
(en)
|
2013-03-14 |
2016-09-20 |
Epizyme, Inc. |
PRMT1 inhibitors and uses thereof
|
JP2016514164A
(ja)
|
2013-03-14 |
2016-05-19 |
エピザイム,インコーポレイティド |
アルギニンメチルトランスフェラーゼ阻害剤としてのピラゾール誘導体およびその使用
|
WO2014153208A1
(en)
|
2013-03-14 |
2014-09-25 |
Epizyme, Inc. |
Arginine methyltransferase inhibitors and uses thereof
|
US9120757B2
(en)
|
2013-03-14 |
2015-09-01 |
Epizyme, Inc. |
Arginine methyltransferase inhibitors and uses thereof
|
EP2970220A2
(en)
*
|
2013-03-14 |
2016-01-20 |
Epizyme, Inc. |
Arginine methyltransferase inhibitors and uses thereof
|
WO2014144659A1
(en)
|
2013-03-14 |
2014-09-18 |
Epizyme, Inc. |
Pyrazole derivatives as prmt1 inhibitors and uses thereof
|
DK2970132T3
(da)
|
2013-03-14 |
2020-12-21 |
Epizyme Inc |
Argininmethyltransferaseinhibitorer og anvendelser deraf
|
KR20150135332A
(ko)
|
2013-03-14 |
2015-12-02 |
더 보드 오브 트러스티스 오브 더 리랜드 스탠포드 쥬니어 유니버시티 |
미토콘드리아 알데히드 탈수소효소-2 조절인자들 및 이들의 사용 방법
|
HUE036925T2
(hu)
*
|
2013-03-15 |
2018-08-28 |
Janssen Pharmaceutica Nv |
C-fms kináz inhibitorként használható helyettesített piridin származékok
|
US20140335079A1
(en)
*
|
2013-05-07 |
2014-11-13 |
Emory University |
Solenopsin and derivatives, therapeutic compositions, and methods related thereto
|
EP3017814B1
(en)
*
|
2013-07-03 |
2018-01-31 |
Mitsubishi-Chemical Foods Corporation |
Method for preventing and/or treating digital dermatitis
|
US9763957B2
(en)
|
2013-07-18 |
2017-09-19 |
Novartis Ag |
Autotaxin inhibitors
|
US20150045435A1
(en)
*
|
2013-08-06 |
2015-02-12 |
Indiana University Research And Technology Corporation |
Compounds and methods for treating diabetes
|
EP3035921A1
(en)
*
|
2013-08-20 |
2016-06-29 |
Bristol-Myers Squibb Company |
Imidazopyridazine kinase inhibitors useful to treating a disease or disorder mediated by aak1, such as alzheimer's disease, bipolar disorder, pain, schizophrenia
|
WO2015027160A2
(en)
*
|
2013-08-22 |
2015-02-26 |
Northeastern University |
Allosteric modulators of the cannibinoid 1 receptor
|
MX2016003215A
(es)
|
2013-09-13 |
2016-11-25 |
Univ Arkansas |
Preparacion y uso de una composicion para la prevencion y mitigacion de los efectos de la radiacion.
|
WO2015050984A1
(en)
*
|
2013-10-01 |
2015-04-09 |
New York University |
Amino, amido, and heterocyclic compounds as modulators of rage activity and uses thereof
|
CA2928078A1
(en)
|
2013-10-22 |
2015-04-30 |
Shire Human Genetic Therapies, Inc. |
Lipid formulations for delivery of messenger rna
|
US9796709B2
(en)
*
|
2013-12-13 |
2017-10-24 |
Daiichi Sankyo Company, Limited |
5-hydroxy-4-(trifluoromethyl)pyrazolopyridine derivative
|
KR20160097366A
(ko)
|
2013-12-17 |
2016-08-17 |
라보라토리오스 델 드라. 에스테브.에스.에이. |
세로토닌-노르에피네프린 재흡수 억제제들(SNRIs) 및 시그마 리셉터 리간드들 조합
|
US9381171B2
(en)
*
|
2013-12-19 |
2016-07-05 |
Samsung Electronics Co., Ltd. |
Composition including dapsone for preventing or treating side effect of steroid in subject and use of the composition
|
WO2015091934A1
(en)
*
|
2013-12-20 |
2015-06-25 |
AbbVie Deutschland GmbH & Co. KG |
Oxindole derivatives carrying an amine-substituted piperidyl-azetidinyl substituent and use thereof for treating vasopressine-related diseases
|
CN104744446B
(zh)
*
|
2013-12-30 |
2019-06-25 |
广东东阳光药业有限公司 |
杂芳化合物及其在药物中的应用
|
AU2015204572B2
(en)
|
2014-01-10 |
2020-07-30 |
Inspirna, Inc. |
LXR agonists and uses thereof
|
US9636298B2
(en)
|
2014-01-17 |
2017-05-02 |
Methylgene Inc. |
Prodrugs of compounds that enhance antifungal activity and compositions of said prodrugs
|
JP6691869B2
(ja)
*
|
2014-02-20 |
2020-05-13 |
コーネル ユニヴァーシティー |
ファシンを阻害するための化合物及び方法
|
TWI672141B
(zh)
|
2014-02-20 |
2019-09-21 |
美商醫科泰生技 |
投予ros1突變癌細胞之分子
|
ES2950384T3
(es)
|
2014-02-28 |
2023-10-09 |
Boehringer Ingelheim Int |
Uso médico de un inhibidor de DPP-4
|
WO2015140199A1
(de)
|
2014-03-21 |
2015-09-24 |
Bayer Pharma Aktiengesellschaft |
Cyano-substituierte imidazo[1,2-a]pyridincarboxamide und ihre verwendung
|
TWI746422B
(zh)
|
2014-05-20 |
2021-11-21 |
美商千禧製藥公司 |
用於癌症治療的方法
|
EP3157520B1
(en)
|
2014-06-23 |
2019-09-04 |
Celgene Corporation |
Apremilast for the treatment of a liver disease or a liver function abnormality
|
WO2016040185A1
(en)
|
2014-09-08 |
2016-03-17 |
Samumed, Llc |
2-(1h-indazol-3-yl)-3h-imidazo[4,5-b]pyridine and therapeutic uses thereof
|
WO2016040180A1
(en)
|
2014-09-08 |
2016-03-17 |
Samumed, Llc |
3-(1h-benzo[d]imidazol-2-yl)-1h-pyrazolo[3,4-c]pyridine and therapeutic uses thereof
|
WO2016040193A1
(en)
|
2014-09-08 |
2016-03-17 |
Samumed, Llc |
3-(1h-imidazo[4,5-c]pyridin-2-yl)-1h-pyrazolo[3,4-b]pyridine and therapeutic uses thereof
|
WO2016040190A1
(en)
|
2014-09-08 |
2016-03-17 |
Samumed, Llc |
3-(3h-imidazo[4,5-b]pyridin-2-yl)-1h-pyrazolo[3,4-b]pyridine and therapeutic uses thereof
|
WO2016040184A1
(en)
|
2014-09-08 |
2016-03-17 |
Samumed, Llc |
3-(3h-imidazo[4,5-b]pyridin-2-yl)-1h-pyrazolo[3,4-c]pyridine and therapeutic uses thereof
|
WO2016040181A1
(en)
|
2014-09-08 |
2016-03-17 |
Samumed, Llc |
3-(1h-imidazo[4,5-c]pyridin-2-yl)-1h-pyrazolo[3,4-c]pyridine and therapeutic uses thereof
|
JP6539345B2
(ja)
*
|
2014-10-24 |
2019-07-03 |
朗齊生物医学股▲分▼有限公司 |
がん治療のための医薬組成物の調製におけるデュロキセチン塩酸塩薬物の使用
|
US10213445B2
(en)
*
|
2014-11-06 |
2019-02-26 |
ARIZONA BOARD OF REGENTS on behalf of THE UNIVERSITY OF ARIZONA, A BODY CORPORATE |
Compositions and methods of diazeniumdiolate-based prodrugs for treating cancer
|
MX2017006022A
(es)
*
|
2014-11-07 |
2017-11-17 |
Univ Northwestern |
Inhibicion de ornitina aminotransferasa con analogos gaba para el tratamiento de carcinoma hepatocelular.
|
CA2969221C
(en)
*
|
2014-12-02 |
2021-01-12 |
Travis Mickle |
Benzoic acid, benzoic acid derivatives and heteroaryl carboxylic acid conjugates of oxymorphone, prodrugs, methods of making and use thereof
|
JP6744309B2
(ja)
|
2014-12-02 |
2020-08-19 |
イグニタ,インコーポレイテッド |
神経芽細胞腫の治療のための併用
|
JP2017536396A
(ja)
|
2014-12-02 |
2017-12-07 |
バイエル・ファルマ・アクティエンゲゼルシャフト |
ヘテロアリール置換イミダゾ[1,2−a]ピリジンおよびその使用
|
AU2015358384B2
(en)
*
|
2014-12-03 |
2021-03-04 |
Auckland Uniservices, Ltd. |
Kinase inhibitor prodrug for the treatment of cancer
|
WO2016094854A2
(en)
*
|
2014-12-12 |
2016-06-16 |
Miradx |
Methods for treating or preventing cancer in a kras-variant patient and for diagnosing risk of developing multiple primary breast tumors
|
JP6951976B2
(ja)
*
|
2015-01-22 |
2021-10-20 |
マイトコン ファーマシューティカルズ, インコーポレイテッド |
神経筋疾患、神経変性疾患、自己免疫疾患、発達疾患および/または代謝疾患の処置のための、脳由来神経栄養因子(bdnf)の誘導された発現
|
JP6891385B2
(ja)
|
2015-03-04 |
2021-06-18 |
バンダ・ファーマシューティカルズ・インコーポレイテッドVanda Pharmaceuticals Inc. |
トラジピタントによる治療方法
|
WO2016154362A1
(en)
|
2015-03-23 |
2016-09-29 |
The Brigham And Women's Hospital, Inc. |
Tolerogenic nanoparticles for treating diabetes mellitus
|
EP3285773A4
(en)
*
|
2015-04-20 |
2019-04-10 |
Epizyme, Inc. |
POLY THERAPY FOR THE TREATMENT OF CANCER
|
ES2898922T3
(es)
*
|
2015-04-30 |
2022-03-09 |
Musc Found For Res Dev |
Compuestos de oxindol y composiciones farmacéuticas de los mismos
|
US20160324914A1
(en)
|
2015-05-05 |
2016-11-10 |
Tocol Pharmaceuticals, Llc |
Use of rice bran oil distillate extract for prevention and mitigation of the effects of radiation
|
TWI713534B
(zh)
|
2015-06-11 |
2020-12-21 |
日商第一三共股份有限公司 |
5-羥基-4-(三氟甲基)吡唑并吡啶衍生物之結晶及其用途
|
GB201511382D0
(en)
|
2015-06-29 |
2015-08-12 |
Imp Innovations Ltd |
Novel compounds and their use in therapy
|
US10206909B2
(en)
|
2015-08-03 |
2019-02-19 |
Samumed, Llc |
3-(1H-pyrrolo[2,3-B]pyridin-2-yl)-1H-pyrazolo[4,3-B]pyridines and therapeutic uses thereof
|
WO2017023996A1
(en)
|
2015-08-03 |
2017-02-09 |
Samumed, Llc. |
3-(1h-pyrrolo[2,3-b]pyridin-2-yl)-1h-pyrazolo[3,4-b]pyridines and therapeutic uses thereof
|
WO2017024025A1
(en)
|
2015-08-03 |
2017-02-09 |
Sunil Kumar Kc |
3-(1h-pyrrolo[2,3-c]pyridin-2-yl)-1h-pyrazolo[4,3-b]pyridines and therapeutic uses thereof
|
WO2017023980A1
(en)
|
2015-08-03 |
2017-02-09 |
Samumed, Llc. |
3-(1h-pyrrolo[2,3-b]pyridin-2-yl)-1h-pyrazolo[3,4-c]pyridines and therapeutic uses thereof
|
WO2017023975A1
(en)
|
2015-08-03 |
2017-02-09 |
Samumed, Llc. |
3-(1h-pyrrolo[2,3-c]pyridin-2-yl)-1h-pyrazolo[3,4-c]pyridines and therapeutic uses thereof
|
WO2017023987A1
(en)
|
2015-08-03 |
2017-02-09 |
Samumed, Llc. |
3-(1h-pyrrolo[3,2-c]pyridin-2-yl)-1h-pyrazolo[3,4-b]pyridines and therapeutic uses thereof
|
US10329309B2
(en)
|
2015-08-03 |
2019-06-25 |
Samumed, Llc |
3-(3H-imidazo[4,5-B]pyridin-2-yl)-1H-pyrazolo[4,3-B]pyridines and therapeutic uses thereof
|
WO2017023989A1
(en)
|
2015-08-03 |
2017-02-09 |
Samumed, Llc. |
3-(1h-benzo[d]imidazol-2-yl)-1h-pyrazolo[4,3-b]pyridines and therapeutic uses thereof
|
WO2017024003A1
(en)
|
2015-08-03 |
2017-02-09 |
Samumed, Llc |
3-(1h-pyrrolo[3,2-c]pyridin-2-yl)-1h-pyrazolo[4,3-b]pyridines and therapeutic uses thereof
|
WO2017024010A1
(en)
|
2015-08-03 |
2017-02-09 |
Samumed, Llc. |
3-(1h-pyrrolo[3,2-c]pyridin-2-yl)-1h-indazoles and therapeutic uses thereof
|
US10604512B2
(en)
|
2015-08-03 |
2020-03-31 |
Samumed, Llc |
3-(1H-indol-2-yl)-1H-indazoles and therapeutic uses thereof
|
WO2017023993A1
(en)
|
2015-08-03 |
2017-02-09 |
Samumed, Llc. |
3-(1h-indol-2-yl)-1h-pyrazolo[4,3-b]pyridines and therapeutic uses thereof
|
WO2017024026A1
(en)
|
2015-08-03 |
2017-02-09 |
Samumed, Llc |
3-(1h-indol-2-yl)-1h-pyrazolo[3,4-c]pyridines and therapeutic uses thereof
|
US10195185B2
(en)
|
2015-08-03 |
2019-02-05 |
Samumed, Llc |
3-(1H-imidazo[4,5-C]pyridin-2-yl)-1H-pyrazolo[4,3-B]pyridines and therapeutic uses thereof
|
WO2017023984A1
(en)
|
2015-08-03 |
2017-02-09 |
Samumed, Llc. |
3-(1h-pyrrolo[3,2-c]pyridin-2-yl)-1h-pyrazolo[3,4-c]pyridines and therapeutic uses thereof
|
US10350199B2
(en)
|
2015-08-03 |
2019-07-16 |
Samumed, Llc |
3-(1h-pyrrolo[2,3-b]pyridin-2-yl)-1h-indazoles and therapeutic uses thereof
|
US10188634B2
(en)
|
2015-08-03 |
2019-01-29 |
Samumed, Llc |
3-(3H-imidazo[4,5-C]pyridin-2-yl)-1 H-pyrazolo[4,3-B]pyridines and therapeutic uses thereof
|
US9675608B2
(en)
*
|
2015-08-26 |
2017-06-13 |
Macau University Of Science And Technology |
Identification of natural small-molecules AMPK activators for treatment of cancers or multidrug-resistant cancers
|
KR20180061363A
(ko)
*
|
2015-10-08 |
2018-06-07 |
쑤저우 운씨엔 이야오 커지 요씨엔 공시 |
Wnt 신호 전달 경로 억제제 및 이의 치료적 적용
|
GB201519450D0
(en)
*
|
2015-11-03 |
2015-12-16 |
Univ Liverpool |
Novel treatment
|
RU2018120728A
(ru)
|
2015-11-06 |
2019-12-09 |
СЭМЬЮМЕД, ЭлЭлСи |
Лечение остеоартрита
|
US9549907B1
(en)
*
|
2015-11-13 |
2017-01-24 |
Sovereign Pharmaceuticals, Llc |
Immediate release oral guaifenesin solution
|
US10765665B2
(en)
*
|
2015-11-24 |
2020-09-08 |
Melin Jeffrey |
Composition comprising combination of rapamycin and an activator of AMP kinase and use thereof for treating diseases
|
AU2016361441B2
(en)
*
|
2015-11-25 |
2021-08-12 |
Convergene Llc |
Bicyclic BET bromodomain inhibitors and uses thereof
|
AU2016370846B2
(en)
|
2015-12-18 |
2022-08-25 |
Ignyta, Inc. |
Combinations for the treatment of cancer
|
JP2019507773A
(ja)
*
|
2016-03-09 |
2019-03-22 |
ネザーランズ トランスレーショナル リサーチ センター ビー.ブイ. |
インドールアミン2,3−ジオキシゲナーゼの阻害剤
|
DK3430004T3
(da)
*
|
2016-03-14 |
2020-09-28 |
Pliva Hrvatska D O O |
Faststofformer af nilotinibsalte
|
US10064834B2
(en)
*
|
2016-05-09 |
2018-09-04 |
Texas Tech University System |
Carbidopa for the treatment of cancer
|
WO2017197036A1
(en)
*
|
2016-05-10 |
2017-11-16 |
C4 Therapeutics, Inc. |
Spirocyclic degronimers for target protein degradation
|
WO2017201712A1
(zh)
*
|
2016-05-26 |
2017-11-30 |
中国热带农业科学院热带生物技术研究所 |
诺卡酮的应用
|
EP3251668A1
(en)
*
|
2016-06-02 |
2017-12-06 |
Pharmotech SA |
Cannabidiol compositions and uses thereof
|
US10155000B2
(en)
|
2016-06-10 |
2018-12-18 |
Boehringer Ingelheim International Gmbh |
Medical use of pharmaceutical combination or composition
|
US10729670B2
(en)
|
2016-09-07 |
2020-08-04 |
Temple University—Of The Commonwealth Systems Of Higher Education |
Compositions and methods for treatment of insulin resistance
|
EP3446703A1
(en)
*
|
2017-08-24 |
2019-02-27 |
Isofol Medical AB |
6r]-mthf multiple bolus administration in 5-fluorouracil based chemotherapy
|
EP3446704A1
(en)
|
2017-08-24 |
2019-02-27 |
Isofol Medical AB |
[6r]-mthf - an efficient folate alternative in 5-fluorouracil based chemotherapy
|
JP2019535672A
(ja)
|
2016-10-21 |
2019-12-12 |
サミュメッド リミテッド ライアビリティ カンパニー |
インダゾール−3−カルボキサミドの使用方法およびwnt/β−カテニンシグナル伝達経路阻害剤としてのそれらの使用
|
EP3534878A1
(en)
|
2016-11-07 |
2019-09-11 |
Samumed, LLC |
Single-dose, ready-to-use injectable formulations
|
EP3541395A4
(en)
|
2016-11-21 |
2020-07-01 |
Viking Therapeutics, Inc. |
GLYCOGENOSIS TREATMENT METHODS
|
US10624370B2
(en)
*
|
2016-12-15 |
2020-04-21 |
Societe Des Produits Nestle S A |
Compositions and methods that modulate digestibility in a companion animal
|
US10723716B2
(en)
|
2016-12-21 |
2020-07-28 |
New York University |
Alpha-helix mimetics as modulators of Abeta self-assembly
|
US10793530B2
(en)
|
2017-01-26 |
2020-10-06 |
Boehringer Ingelheim International Gmbh |
Benzylaminopyrazinylcyclopropanecarboxylic acids, pharmaceutical compositions and uses thereof
|
WO2018138030A1
(en)
|
2017-01-26 |
2018-08-02 |
Boehringer Ingelheim International Gmbh |
Benzyloxypyrazinylcyclopropanecarboxylic acids, pharmaceutical compositions and uses thereof
|
WO2018138027A1
(en)
|
2017-01-26 |
2018-08-02 |
Boehringer Ingelheim International Gmbh |
Benzylaminopyridylcyclopropanecarboxylic acids, pharmaceuticalcompositions and uses thereof
|
US10913720B2
(en)
|
2017-01-26 |
2021-02-09 |
Boehringer Ingelheim International Gmbh |
Benzyloxypyridylcyclopropanecarboxylic acids, pharmaceutical compositions and uses thereof
|
JP7049353B2
(ja)
|
2017-02-08 |
2022-04-06 |
ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング |
糖尿病の治療のためのインダニルアミノアザジヒドロベンゾフラニル酢酸、医薬組成物
|
BR112019016668A2
(pt)
|
2017-02-14 |
2020-04-07 |
Isofol Medical Ab |
métodos para aumentar a concentração de plasma de durd e para inibir timidilato-sintase (ts) em um indivíduo humano.
|
US10517842B2
(en)
*
|
2017-03-15 |
2019-12-31 |
Los Angeles Biomedical Research Institute At Harbor-Ucla Medical Center |
Methods of modulating miRNA levels and compositions for use in the same
|
RU2675496C1
(ru)
*
|
2017-03-31 |
2018-12-20 |
Федеральное государственное бюджетное учреждение науки Институт нефтехимии и катализа Российской академии наук |
Способ получения алкиловых эфиров гидроксибензойных кислот
|
EP3600282A4
(en)
|
2017-03-31 |
2020-08-19 |
Corcept Therapeutics, Inc. |
GLUCOCORTICOID RECEPTOR MODULATORS FOR THE TREATMENT OF COLD CANCER
|
US20180280319A1
(en)
*
|
2017-04-04 |
2018-10-04 |
University Of The Sciences |
Compounds and compositions for treatment of breast cancer
|
FR3066393B1
(fr)
*
|
2017-05-16 |
2019-07-19 |
Polyneuros |
Principe actif constitue par un melange de composes poly-lysine et utilisation dans la prevention des avc et le traitement de la phase inflammatoire post-avc
|
US11491150B2
(en)
|
2017-05-22 |
2022-11-08 |
Intra-Cellular Therapies, Inc. |
Organic compounds
|
CN110996966A
(zh)
|
2017-06-05 |
2020-04-10 |
维京治疗公司 |
用于治疗纤维化的组合物
|
BR112020000793A2
(pt)
|
2017-07-19 |
2020-07-14 |
Ignyta, Inc. |
composições farmacêuticas e formas de dosagem
|
US10639313B2
(en)
*
|
2017-09-01 |
2020-05-05 |
Ndsu Research Foundation |
Compound for inhibition of delta-5-desaturase (D5D) and treatment of cancer and inflammation
|
CN111093671A
(zh)
|
2017-09-13 |
2020-05-01 |
万达制药公司 |
以托吡坦对特应性皮炎的改进治疗
|
US10342786B2
(en)
|
2017-10-05 |
2019-07-09 |
Fulcrum Therapeutics, Inc. |
P38 kinase inhibitors reduce DUX4 and downstream gene expression for the treatment of FSHD
|
WO2019071144A1
(en)
|
2017-10-05 |
2019-04-11 |
Fulcrum Therapeutics, Inc. |
USE OF P38 INHIBITORS TO REDUCE DUX4 EXPRESSION
|
WO2019077506A1
(en)
|
2017-10-17 |
2019-04-25 |
Ignyta, Inc. |
PHARMACEUTICAL COMPOSITIONS AND SOLID GALENIC FORMS
|
WO2019084323A1
(en)
*
|
2017-10-25 |
2019-05-02 |
Georgia State University Research Foundation, Inc. |
CHEMICAL RELEASE SYSTEM DELIVERED BY ENRICHMENT
|
CA3081751A1
(en)
|
2017-11-03 |
2019-05-09 |
Aclaris Therapeutics, Inc. |
Substituted pyrrolopyrimidine jak inhibitors and methods of making and using the same
|
WO2019104062A1
(en)
|
2017-11-21 |
2019-05-31 |
Rgenix, Inc. |
Polymorphs and uses thereof
|
EP3768690A4
(en)
|
2018-03-22 |
2021-11-24 |
Viking Therapeutics, Inc. |
CRYSTALLINE SHAPES AND METHOD FOR MAKING CRYSTALLINE SHAPES OF A COMPOUND
|
WO2019191032A1
(en)
|
2018-03-26 |
2019-10-03 |
Clear Creek Bio, Inc. |
Compositions and methods for inhibiting dihydroorotate dehydrogenase
|
SG11202011948SA
(en)
|
2018-06-04 |
2020-12-30 |
Corcept Therapeutics Inc |
Pyrimidine cyclohexenyl glucocorticoid receptor modulators
|
SG11202100525SA
(en)
|
2018-08-10 |
2021-02-25 |
Aclaris Therapeutics Inc |
Pyrrolopyrimidine itk inhibitors
|
US11389432B2
(en)
|
2018-12-19 |
2022-07-19 |
Corcept Therapeutics Incorporated |
Methods of treating cancer comprising administration of a glucocorticoid receptor modulator and a cancer chemotherapy agent
|
CN113194931B
(zh)
|
2018-12-19 |
2023-11-10 |
科塞普特治疗公司 |
含有瑞拉可兰、杂芳基-酮稠合的氮杂十氢化萘化合物的药物制剂
|
US11234971B2
(en)
|
2018-12-19 |
2022-02-01 |
Corcept Therapeutics Incorporated |
Methods of treating cancer comprising administration of a glucocorticoid receptor modulator and a cancer chemotherapy agent
|
KR20220004726A
(ko)
|
2019-05-02 |
2022-01-11 |
어클라리스 쎄라퓨틱스, 인코포레이티드 |
Jak 억제제로서의 치환된 피롤로피리딘
|
JP2023505948A
(ja)
|
2019-12-11 |
2023-02-14 |
コーセプト セラピューティクス, インコーポレイテッド |
抗精神病薬誘発性体重増加のミリコリラントによる治療方法
|
CA3161274A1
(en)
|
2019-12-13 |
2021-06-17 |
Stephen Wald |
Metal salts and uses thereof
|
AU2021268944B2
(en)
|
2020-05-06 |
2024-04-18 |
Corcept Therapeutics Incorporated |
Polymorphs of pyrimidine cyclohexyl glucocorticoid receptor modulators
|
US11071739B1
(en)
|
2020-09-29 |
2021-07-27 |
Genus Lifesciences Inc. |
Oral liquid compositions including chlorpromazine
|
US11865139B2
(en)
|
2020-11-12 |
2024-01-09 |
Thermolife International, Llc |
Method of treating migraines and headaches
|
WO2022140293A1
(en)
|
2020-12-21 |
2022-06-30 |
Corcept Therapeutics Incorporated |
Method of preparing pyrimidine cyclohexyl glucocorticoid receptor modulators
|
CN113354558B
(zh)
*
|
2021-07-12 |
2022-03-11 |
无锡双启科技有限公司 |
一种2-氨基-5-氟苯腈的制备方法
|